• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Talaris Therapeutics

layoff staff workforce
Biotech

2023 biopharma layoffs now match 2022's total

Layoffs in biotech for 2023 have matched the total number of companies that cut staff in all of 2022, according to an analysis of Fierce Biotech data. 
Gabrielle Masson Aug 21, 2023 11:37am
merger handshake

Talaris reverse merger tees up midphase trials of ex-Pfizer drug

Jun 22, 2023 9:50am
layoffs job cuts workforce reduction layoff

Talaris lays off 95% of workforce after fruitless deal hunt

Apr 17, 2023 9:38am
organ transplant surgery cooler organ transplantation

Talaris ends recently restarted kidney transplant studies

Feb 16, 2023 11:00am
Kidney

Talaris restarts trial after assurance regarding patient death

Oct 20, 2022 10:05am
Publicly traded hotel companies beholden to Wall Street

Talaris pulls off $150M IPO to tackle organ rejection

May 7, 2021 10:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings